Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 79 citing GLAZER: Live cytomegalovirus vaccination of renal transplant candidates: a preliminary trial. (0.09 sec) 

Impact of cytomegalovirus infection on organ transplant recipients


RH Rubin - Reviews of infectious diseases, 1990 - jstor.org
Page 1. REVIEWS OF INFECTIOUS DISEASES * VOL. 12, SUPPLEMENT 7 * SEPTEMBER-
OCTOBER 1990 O 1990 by The University of Chicago. All rights reserved. 0162-0886/90/1205-
0047$02.00 Impact of Cytomegalovirus Infection on Organ Ttansplant Recipients ...
Cited by 337 - Related articles - All 2 versions

Infections in solid-organ transplant recipients

- nih.gov [PDF] 
R Patel, CV Paya - Clinical microbiology reviews, 1997 - Am Soc Microbiol
INTRODUCTION.........................................................................................................................................
................86 PRETRANSPLANTATION INFECTIOUS DISEASE EVALUATION AND POSTTRANSPLANTATION
COUNSELING...................................... ... ... Solid organ transplantation is a therapeutic ...
Cited by 347 - Related articles - BL Direct - All 10 versions

Cytomegalovirus infections following renal transplantation


J Glenn - Reviews of infectious diseases, 1981 - jstor.org
This collective review of the literature concerns posttransplantation cytomegalovirus (CMV)
infections. In the author's view, patients without previous CMV infection are most often infected
by viruses transmitted with the transplanted kidney, whereas pa- tients with prior ...
Cited by 212 - Related articles - All 2 versions

Maternal cytomegalovirus infection and perinatal transmission


S Stagno, RF Pass, ME Dworsky, CA … - Clinical Obstetrics and …, 1982 - journals.lww.com
564 STAGNO ET AL. TABLE 1. Public Health Impact of Congenital CMV Infection in the USA
Estimated figure No. of live births per year in USA 3,000,000 Rate of congenital CMV infection
(average) 1% No. of infected infants 30,000 Symptomatic at birth (5-10%) 1,500-3,000 ...
Cited by 140 - Related articles - All 2 versions

Latent infection and the elusive cytomegalovirus


MC Jordan - Reviews of Infectious Diseases, 1983 - jstor.org
The ability of herpesviruses to persist in the host's tissues for many years after the initial infection
is an important biological characteristic [1, 2]. Dur- ing the past decade, considerable effort has
been put forth to define experimentally the sites and mechanisms of latency for two ...
Cited by 121 - Related articles - All 2 versions

Murine monoclonal antibody to a single protein neutralizes the infectivity of human …

- pnas.org [PDF] 
LE Rasmussen, RM Nelson, DC Kelsall, … - Proceedings of the …, 1984 - National Acad Sciences
Page 1. Proc. Nati. Acad. Sci. USA Vol. 81, pp. 876-880, February 1984 Immunology Murine
monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus
(immunoprecipitation/virus neutralization/immunofluorescence/strains) ...
Cited by 104 - Related articles - All 9 versions

Towne-vaccine-induced prevention of cytomegalovirus disease after renal …


SA Plotkin, HM Friedman, GR Fleisher, DC Dafoe, RA … - The Lancet, 1984 - Elsevier
91 renal transplant candidates were randomised to receive Towne strain cytomegalovirus
(CMV) vaccine or placebo at least 8 weeks before transplantation. The vaccine was well tolerated
and there was no vaccine virus excretion. Serological and cellular immune responses ...
Cited by 105 - Related articles - All 6 versions

Immunity induced by primary human cytomegalovirus infection protects against …


SP Adler, SE Starr, SA Plotkin, SH Hempfling, J … - The Journal of infectious …, 1995 - jstor.org
Page 1. 26 Immunity Induced by Primary Human Cytomegalovirus Infection Protects against
Secondary Infection among Women of Childbearing Age Stuart P. Adler, Stuart E. Starr, Stanley
A. Plotkin, Sue H. Hempfling, Judy Buis, Mary Lou Manning, and Al M. Best ...
Cited by 102 - Related articles - BL Direct - All 4 versions

The role of pretransplant immunity in protection from cytomegalovirus disease …


M SMILEY, CG WLODAVER, RA GROSSMAN, CF … - Transplantation, 1985 - journals.lww.com
August, 1985 WÖLPL ET AL. 157 1972; 12: 21. 3. Alper CA, Johnson AM, Birtch AG, Moore
FD. Human C3: evi- dence for the liver as the primary site of synthesis. Science 1969; 163:
286. 4. Hobart MJ, Lachmann PJ, Calne RY. C6: synthesis by the liver in vivo. J Exp Med ...
Cited by 88 - Related articles - All 3 versions

Clinical reinfection with varicella-zoster virus


AA Gershon, SP Steinberg, L Gelb - The Journal of infectious diseases, 1984 - jstor.org
Page 1. THE JOURNAL OF INFECTIOUS DISEASES * VOL. 149, NO. 2 * FEBRUARY
1984 @ 1984 by The University of Chicago. All rights reserved. 0022-1899/84/4902-
0002$01.00 Clinical Reinfection with Varicella-Zoster Virus ...
Cited by 72 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google